SHZ · 000518.SZ
Jiangsu Sihuan Bioengineering Co., Ltd
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
Loading market information…
SHH · 688670.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Jiangsu gdk Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 62.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jiangsu gdk Biotechnology Co., Ltd.’s forward annual dividend is CN¥0.20 per share, paid annual. The forward yield is 1.69% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Jiangsu gdk Biotechnology Co., Ltd.’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jiangsu gdk Biotechnology Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jiangsu gdk Biotechnology Co., Ltd. operates as a biotechnology firm specializing in the comprehensive research, development, manufacturing, and commercialization of human vaccines, alongside providing related services. Its current portfolio includes a quadrivalent split-virus influenza vaccine and a lyophilized human rabies vaccine. The company's pipeline is strategically focused on preventing major infectious diseases such as influenza, rabies, chickenpox, shingles, and pneumonia. This enterprise was established in 2008 and is headquartered in Taizhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:34 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
CN¥28.45-CN¥1.46 (-4.88%)
Shaanxi Kanghui Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.36% below the high.
CN¥23.96-CN¥0.88 (-3.54%)
Hubei Goto Biopharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.46% below the high.
CN¥21.10-CN¥0.08 (-0.38%)
Zhejiang East Asia Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 25.42% below the high.
CN¥7.70-CN¥0.16 (-2.04%)
Jiangsu Nanfang Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.89% below the high.
CN¥11.00-CN¥0.80 (-6.78%)
Shandong Sito Bio-technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.39% below the high.
CN¥7.37-CN¥0.15 (-1.99%)
Guiyang Xintian Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.7% below the high.
CN¥5.34-CN¥0.13 (-2.38%)
Tiansheng Pharmaceutical Group Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 14.97% below the high.
